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Membrane transportThe mitochondrial oxoglutarate carrier belongs to the mitochondrial carrier family and exchanges
oxoglutarate for malate and other dicarboxylates across the mitochondrial inner membrane. Here, single-
cysteine mutant carriers were engineered for every residue in the amino- and carboxy-terminus, cytoplasmic
loops, and matrix α-helices and their transport activity was measured in the presence and absence of
sulfhydryl reagents. The analysis of the cytoplasmic side of the oxoglutarate carrier showed that the
conserved and symmetric residues of the mitochondrial carrier motif [DE]XX[RK] localized at the C-terminal
end of the even-numbered transmembrane α-helices are important for the function of the carrier, but the
non-conserved cytoplasmic loops and termini are not. On the mitochondrial matrix side of the carrier most
residues of the three matrix α-helices that are in the interface with the transmembrane α-helical bundle are
important for function. Among these are the residues of the symmetric [ED]G motif present at the C-terminus
of the matrix α-helices; the tyrosines of the symmetric YK motif at the N-terminus of the matrix α-helices;
and the hydrophobic residues M147, I171 and I247. The functional role of these residues was assessed in the
structural context of the homology model of OGC. Furthermore, in this study no evidence was found for the
presence of a speciﬁc homo-dimerisation interface on the surface of the carrier consisting of conserved,
asymmetric and transport-critical residues.ethanethiosulfonate; MTSET,
bromide; OGC, oxoglutarate
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Themitochondrial oxoglutarate carrier (OGC) in themitochondrial
inner membrane plays a central role in the malate/aspartate shuttle,
which transfers reducing equivalents from cytosolic NADH to matrix
NAD+ via a series of enzymatic and transport steps. The carrier also
participates in the oxoglutarate/isocitrate shuttle, in nitrogen metab-
olism, and in gluconeogenesis from lactate when the carbon skeleton
is provided by oxoglutarate exported from the mitochondrion [1,2].
The function of OGC has been investigated in mitochondria and inliposomes reconstituted with protein puriﬁed from native mem-
branes [3–8]. The carrier catalyzes the transport of oxoglutarate in
electroneutral exchange for malate or other dicarboxylates, is
inhibited by organic mercurials and impermeable substrate analo-
gues, such as phtalonate and phenylsuccinate, and behaves kinetically
according to a sequential mechanism.
The determination of the amino acid sequence of OGC [9] showed
that this transporter belongs to a large family of related transport
proteins, called the mitochondrial carrier family [10–14]. The primary
structure of the family members consists of three tandemly repeated
homologous domains [15] of about 100 amino acids in length, each
containing two hydrophobic segments. Furthermore, a characteristic
sequence motif P-X-[DE]-X-X-[RK] is present in all members of the
family and in all three repeats (PROSITE PS50920 and PFAM PF00153)
[14,16]. The atomic model of the bovine mitochondrial ADP/ATP
carrier, which is a member of the protein family, has clariﬁed the
structure of these sequence features [17]. Basically, the ADP/ATP
carrier 3D structure is composed of six transmembrane α-helices
(H1–H6) and three shortα-helices (h12, h34 and h56) situated on the
matrix side and parallel to the membrane plane. H1–H6 line a water-
accessible cavity which is open towards the cytosol and closed on the
303D.V. Miniero et al. / Biochimica et Biophysica Acta 1807 (2011) 302–310matrix side by a salt-bridge network formed by the charged residues
of the three signature motifs PX[DE]XX[RK]. This structure corre-
sponds to the cytoplasmic-state (c-state) of the mitochondrial carrier
proteins and is three-fold pseudo-symmetric. During their catalytic
transport cycle, mitochondrial carriers undergo a reversible transition
between the c-state and the matrix state (m-state), in which the
internal carrier cavity is open towards the matrix and closed on the
cytosolic side by a recently proposed salt-bridge network formed by
the charged residues of the three-fold repeated [DE]XX[RK]motif [18].Fig. 1. Initial uptake rate of 2-oxoglutarate by cysteine-less OGC, deletion and single cystei
cytoplasmic loops: (a) deletion of residues 1-11; (b) single Cys replacements of M12 to P20
Y214; (e) deletions of residues 310-314 and 307-314; and (f) single Cys replacements of E301
2-oxo-[1-14C]-glutarate to proteoliposomes containing 20 mM 2-oxoglutarate. Initial uptake
data are expressed as percentage of the cysteine-less OGC value, which was on average 2219
E301C to K305C were taken from refs. [8,21]. The transport activity of mutant P20C, which w
least three independent experiments carried out in duplicate are shown.The OGC has been the ﬁrst eukaryotic membrane protein to be
expressed in Escherichia coli and refolded in the reconstitutively active
state [19]. This methodology paved the way to using site-directed
mutagenesis to elucidate structure-function relationships of this
important transporter. These studies showed that the three cysteine
residues present in the primary structure of the bovine OGC are not
involved in transport mechanism, because the cysteine-less mutant is
fully active [8]. More recently, in the cysteine-less mutant of OGC, the
residues of the even- and odd-numbered transmembrane α-helicesne replacement mutant carriers of the termini, C-terminal ends of H2, H4 and H6 and
; (c) single Cys replacements of E107 to P117; (d) single Cys replacements of S203 to
to R309 (see Fig. S1 in Supplementary material). Transport was started by adding 3mM
rates of oxoglutarate/oxoglutarate exchange were determined after 30 s of uptake. The
±356 nmol min-1 mg-1 of protein. Data relative to mutants from S203 to S205 and from
as not expressed, could not be assayed (N.D., not determined). The means±S.D. of at
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conjunction with labeling studies of single Cys mutants with the
highly hydrophilic methanethiosulfonate SH-blocking reagents, this
systematic study has led to the identiﬁcation of residues that are
important for the function of the carrier [20,21]. In particular, residues
that are in the area of the proposed substrate binding site [22,23] and
in the signature motifs of the mitochondrial carrier family members
were found to be critical for function [20,21].
Here, the role of residues in the termini, cytoplasmic loops and
matrix α-helices of OGC was investigated, completing the cysteine-
scanning analysis of this important carrier. The present study
highlights several amino acid positions located on the matrix andFig. 2. Initial uptake rate of 2-oxoglutarate by cysteine-less OGC and by single cysteine-repla
acid code along the horizontal axis denotes the original residues replaced with Cys from L51
R246 to F275 in matrix α-helix h56 (c). The experimental details are described in the legend
assayed (N.D., not determined). The means±S.D. of at least three independent experimentcytosolic sides of OGC that are critical for the function of this carrier
and relevant for the transport mechanism. Furthermore, the study
shows that none of the residues on the surface of OGC are likely to be
competent to form a speciﬁc homo-dimerisation interface.
2. Materials and methods
2.1. Materials
2-Oxo[1-14C]glutaric acid was purchased from Dupont De Nemours
(Milan, Italy); PIPES, Triton X-114, Amberlite XAD-4 and egg yolk
phospholipids (lecithin from eggs) from Fluka (Milan, Italy); N-cement mutant carriers for matrix α-helices h12, h34 and h56. The single-letter amino
to L77 in matrix α-helix h12 (a), from R146 to P178 in matrix α-helix h34 (b), and from
of Fig. 1. The transport activity of mutant H66C, which was not expressed, could not be
s carried out in duplicate are shown.
305D.V. Miniero et al. / Biochimica et Biophysica Acta 1807 (2011) 302–310dodecanoylsarcosine (sarkosyl) from Sigma (Milan, Italy); MTSES and
MTSET fromFluorescent Dyes Inc. (Toronto, Canada); and SephadexG-75
from Pharmacia (Milan, Italy). All other reagents were of analytical grade.
2.2. Mutagenesis and functional analysis of OGC
The cloning, expression, puriﬁcation and reconstitution of recom-
binant OGC from sarkosyl were carried out as described previously
[20,21]. To assay the reconstitution efﬁciency, the amount of OGC
incorporated into liposomes was estimated as described [24]. The
functional analysis in the presence and absence of sodium-(2-
sulfonatoethyl)-methane-thiosulfonate (MTSES) or [2-(trimethylam-
monium)ethyl]methanethiosulfonate bromide (MTSET) was carried
out as described [20,21].
2.3. Analysis of amino acid substitutions and structural mapping
The OGC orthologs were identiﬁed in the following organisms:
Anopheles gambiae, Drosophila melanogaster, D. pseudoobscura, Caenor-
habditis elegans, C. briggsae, Bos taurus, Homo sapiens, Oryza sativa, PanFig. 3. Transport of 2-oxoglutarate by single replacement mutants in the wild-type OGC back
residue replacements in matrix α-helix h12 (a), C-terminal end of H2 and cytosolic loops
Transport was started by adding 3 mM 2-oxo-[1-14C]-glutarate to proteoliposomes contain
were determined after 30 s of uptake. The data are expressed as percentage of the wild-typ
least three independent experiments carried out in duplicate are shown.troglodytes, Pongo pygmaeus,Musmusculus, Rattus norvegicus,Danio rerio,
Xenopus laevis and Tetraodon nigroviridis. The sequences were obtained
fromUniProt (http://www.ebi.uniprot.org/). The aminoacid sequencesof
the orthologs were aligned with CLUSTALW [25] and the number of
amino acid substitutions per position was counted. The amino acid
substitution and the effects of themutationsweremapped on a structural
model of the bovine OGC, which was built based on the structure of the
bovine AAC1, as described [21].
3. Results
3.1. Transport activity of reconstituted single cysteine OGC mutants
Each amino acid residue on the cytoplasmic and matrix side of OGC
was replaced with a cysteine by using a functional cysteine-less OGC as a
template. The residueswhichhavebeen substituted are indicated in black
in the OGC topology model (see Fig. S1 in Supplementary material). The
expression levels of the mutant OGC, overproduced in Escherichia coli,
ranged between 52% and 98% as compared to those of thewild-typeOGC,
except for H66C and P20C, which were not expressed at all. Theground. The single-letter amino acid code along the horizontal axis denotes the speciﬁc
between H2-H3 and H4-H5 (b), matrix α-helix h34 (c) and matrix α-helix h56 (d).
ing 20 mM 2-oxoglutarate. Initial uptake rates of oxoglutarate/oxoglutarate exchange
e OGC value, which was 2723±392 nmol min-1 mg-1 of protein. The means±S.D. of at
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and the yield of reconstituted wild-type and mutant proteins varied
between 18% and 35% of the added protein. The initial transport rates of
2-oxoglutarate for each recombinant OGC were measured and
expressed as a percentage of the value for the cysteine-less carrier for
the cytoplasmic (Fig. 1) and matrix side (Fig. 2).
The ﬁrst 11 residues of OGCwere not critical for the function of the
carrier, as they could be deleted collectively without abolishing
activity (Fig. 1a). The single cysteine replacements of the following
eight residues of the N-terminus reduced incrementally the transport
activity, but the transporter remained functional (Fig. 1b). These
results show that the N-terminus was not critical for function of the
carrier. Very few cysteine replacements in the C-terminal ends of the
even-numbered α-helices and in the cytoplasmic loops affected
transport activity (Figs. 1c and d). Among the ones with a severe effect
on transport were E107C, P117C, S203C and L209C in the C-terminal
ends of α-helices H2 and H4. The C-terminus was also not critical
for function as residues 310–314 or 307–314 could be deleted from
OGC without severe empairment of activity, i.e., transport rate higher
than 15% as compared to that of the wild-type carrier (Fig. 1e).
Also, the individual cysteine replacements in this region did not lead
to an inactivated carrier from residues R309 to K305 (Fig. 1f). On
the contrary, single cysteine replacements of the preceding residues
E301, M303 and N304 resulted in inactive carriers (Fig. 1f). On
the matrix side of OGC the vast majority of cysteine replace-
ments that affected the function of the carrier were in the interface
between the matrix α-helices and odd-numbered α-helices (Fig. S2
in Supplementary material), including those of residues Y61, E75, and
G76 on matrix α-helix h12 (Fig. 2a), R146, M147, D150, R158, R159,
Y161, N163, I171 and E175 on matrix α-helix h34 (Fig. 2b), and R246,
I247, Q248, Y259, V270, E273, G274 on matrix α-helix h56 (Fig. 2c).
The effects of the mutations on the initial transport rate were mapped
on the comparativemodel of OGC (Fig. S2 in Supplementarymaterial).
To exclude the possibility that the loss of transport activity was due
to combinations of mutations many of the above-mentioned mutations
were cloned in a wild-type gene background also (Fig. 3). Most single
cysteine replacements inwild-typeOGChada similar effect on transport
as in the cysteine-less OGC, except for E107C, P117C, D150C, L209C
(Figs. 3b and c), V270C(Fig. 3d),M303CandN304C [21]where theeffect
was less severe, i.e., between 20% and 40% of the initial rate of the wild-
type. On the whole, conservative replacements, such as Y61F, G76A,
N163Q, I171V and I247L, had smaller effects on transport than cysteine
replacements. The Y61Hmutation did not affect transport much either,
as Tyr and His are both polar and aromatic residues.
3.2. Effect of sulfhydryl reagents on the transport activity of OGC mutants
The negatively charged MTSES and positively charged MTSET
sulfhydryl reagents, which are both membrane impermeable [26,27],
were used to probe the effect of cysteine modiﬁcations on transport.
The residual transport activity after modiﬁcation with MTSES and
MTSET is shown in Figs. 4 and 5 for all but P20C and H66C, whichwere
not expressed, and the mutant carriers that lacked transport activity.
The mutants S205C, Y214C, L51C, L68C, I71C, T148C, A149C, N249C,Fig. 4. Effect of sulfhydryl reagents on the rate of 2-oxoglutarate uptake by cysteine-lessOGC
or by single cysteine-replacement mutant carriers on the cytoplasmic side. Shown along
the horizontal axis are the cysteine replacements in the N-terminus (a), C-terminal end of
α-helix H2 and cytoplasmic loop between H2 and H3 (b), C-terminal end of α-helix H4
and cytoplasmic loop between H4 and H5 (c), and C-terminal end of α-helix H6 and C-
terminus (d). Proteoliposomes were preincubated in the presence or absence of 5 mM
MTSES or MTSET and transport was started by adding 0.3 mM 2-oxo-[1-14C]-glutarate to
proteoliposomes containing 20 mM 2-oxoglutarate. Initial uptake rates of oxoglutarate/
oxoglutarate exchange were determined after 30 s of uptake. The black and grey bars
represent the percent of the activity in the presence of MTSES or MTSET, respectively,
with respect to the control value without inhibitor. Mutant carriers that were severely
affected by the cysteine replacement and P20C, which was not expressed, could not be
assayed (N.D., not determined).
Fig. 5. Effect of sulfhydryl reagents on the rate of 2-oxoglutarate uptake by cysteine-less OGC or by single cysteine-replacement mutant carriers of the matrixα-helices h12, h34, and
h56. Shown along the horizontal axis are the cysteine replacements in matrix α-helix h12 (a), h34 (b), and h56 (c). The experimental details are described in the legend of Fig. 4.
Mutant carriers that were severely affected by the cysteine replacement and H66C, which was not expressed, could not be assayed (N.D., not determined).
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MTSES and/or MTSET. Remarkably, the modiﬁcation of R170C with
the positively charged MTSET stimulated the transport rate of the
mutant carrier two-fold (Fig. 5). However, sulfhydryl modiﬁcation of
residues S70 and K268, which are in equivalent positions of R170C in
the other repeats, did not affect carrier activity (Fig. 5). The results
obtained with MTSES were mapped on the structural model of OGC
(Fig. S3 in Supplementary material).
3.3. Conservation of OGC orthologs
In general, the N- and C-termini of mitochondrial carriers are variable
in length and composition and the subfamily of oxoglutarate carriers is no
exception (Fig. S4 in Supplementary material). The two cytoplasmic
loops, following H2 and H4, respectively, are also not strictly conserved
between OGC orthologs (Fig. S4 in Supplementary material). However,
the matrix α-helices have a relatively well-conserved face, which formsthe interface with the transmembrane α-helices, and a face with low
conservation,which interactswith themembrane and thewater phase of
the mitochondrial matrix (Fig. S4 in Supplementary material).
4. Discussion
In this study, the cysteine-scanning analysis of OGC has been
completed, and the functional relevance of the currently investigated
carrier regions has been assessed in the structural context of the OGC
homology model [20,21] based on the bovine ADP/ATP carrier [17].
4.1. C-terminal end of the odd-numbered α-helices of the oxoglutarate
carrier
In previous work [20], we observed that Cys-substitution of Q50
resulted in inactivation of theOGC. The results presentedhere show that
the symmetry-related residues Q248 and T148 are also inactived by Cys
308 D.V. Miniero et al. / Biochimica et Biophysica Acta 1807 (2011) 302–310replacement (Fig. 2) and sulphydryl modiﬁcation (Fig. 5), respectively.
These three residues are likely to be interactingwith the charge residues
of the matrix salt-bridge network [16,17], which is involved in the
opening/closing of the mitochondrial carrier gate on the matrix side
[11,18]. In addition, Cys replacement of the neighbouring residues L51,
A149, and N249 does not affect the function of OGC (Fig. 2), but the
subsequent modiﬁcation of the cysteines with MTSES and MTSET at
these positions markedly reduces the OGC transport activity (Fig. 5).
Residues L51, A149, and N249 aremost likely in the passageway for the
substrate (Fig. 6d). Thus, they become exposed when the carrier opens
towards the matrix side and labeling of these mutant proteins with
methanethiosulphonate SH-blocking reagents lead to inhibition of
transport.
4.2. The matrix α-helices of the mitochondrial oxoglutarate carrier
The matrix α-helices link the odd- and even-numbered trans-
membrane α-helices in each repeat [17], but their function is not yet
understood. Most residues of the OGCmatrixα-helices are not critical
for function (Fig. 2) in agreement with the conservation (Fig. S4
in Supplementary material) and symmetry analysis [18]. Residues
important for function are found in the interface of the matrix α-Fig. 6.Overview and details of the areas that most affect the function of OGC after cysteine rep
from themembrane of the comparativemodel of OGC based on the structure of themitochon
red, whereas cysteine replacements that abolish transport activity after labeling with sulfh
panel (c), (d) and (e). Panels (c) and (e) show the cytoplasmic side and matrix side of the st
matrix salt bridge network. The residues are labelled also with their one-letter amino a
cytoplasmic network in thematrix state schematically. In panel (e) putative interactions betw
been reported previously [20], but they have been added because they are pseudo-symmethelices with the odd-numbered α-helices (Fig. 6e). Among them are
the residues Y61, E75, G76, Y161, E175, G176, Y259, E273 and G274 of
the YK and [ED]G motifs that upon substitution with cysteine cause a
signiﬁcant impairment of the carrier's transport ability (Fig. 2). The
inhibition of OGC activity by Cys replacement of E at position 75, 175
and 273 are the ﬁrst evidence in favour of a putative salt bridge in OGC
between the glutamates and the conserved and three-fold repeated
positively charged residue, two residues C-terminal of the signature
motif PX[ED]XX[RK], as found in the crystalline structure of the ADP/
ATP carrier [17]. The hydroxyl groups of tyrosines Y61, Y161 and Y259
are in the vicinity of the matrix salt bridge and might interact with
these residues (Fig. 6e). G76, G176 and G274 are highly conserved in
thewholemitochondrial carrier family andmay provide a ﬂexible link
between the matrix and the short linker α-helices, which are present
at the N-terminal end of the even-numbered α-helices (Fig. 6e). The
role of residues M147, I171 and I247 at the interface between the
matrix and transmembrane α-helices is not clear, but their position
might indicate that mutations of these residues could disrupt this
interface (Figs. 2 and 6e). In addition, sulfhydryl modiﬁcations of I71C
and V265C partially prevent the carrier from functioning (Fig. 5),
indicating that the accessibility of the interface might change during
the transport cycle, as was also proposed for the ADP/ATP carrier [28].lacement ormodiﬁcationwith sulfhydryl reagents. (a) Cytoplasmic and (b) lateral view
drial ADP/ATP carrier. Cysteine replacements that abolish transport activity are coloured
ydryl reagents are coloured yellow. Dashed boxes indicate the three sections shown in
ructural model of OGC, respectively, whereas panel (d) shows the area just beneath the
cid code and their residue number. Panel (c) shows the putative interactions of the
een residues are shown in green dotted lines. The results for residues R48 and Q50 have
rically related to residues R146 and R246, and T148 and Q248, respectively.
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On the cytoplasmic side of mitochondrial carriers the residues of
themotif [DE]XX[RK] localized at the C-termini of the even-numbered
α-helices may form a salt-bridge network as part of the cytosolic gate
in the matrix state [11,18]. In the bovine OGC the residues of this motif
are partially conserved: ERLT in H2, SQSK in H4, and EQMN in H6
(Fig. 6c). The residues T110 and S203 as well as N304 and E107 might
form hydrogen bonds instead, although it is not clear whether the
distance between the side chains would be sufﬁcient (Fig. 6c). It is
notable that replacement with cysteine of E107, S203, E301 and N304
causes a severe inactivation of OGC (Fig. 1), although in the case of
E107C and N304C the inhibition is less pronounced in the wild-type
than in the cysteine-less background. It is worth mentioning that
modiﬁcation of the cysteines replacing residues K122 [20], Y214 (Fig. 4),
S226 [20], T296 and F299 [21] with sulfhydryl reagents lead to a
dysfunctional carrier. Given that all of these residues are very close to
the hypothesized cytosolic gate, it is possible that these modiﬁcations
interfere with the closure/opening of OGC on the cytosolic side in the
transport cycle. It should be added that we have previously reported
that the mutants Y102C, Y202C and F297C exhibit an almost complete
inhibition of oxoglutarate transport [8,21]. These aromatic residues
precede the [DE]XX[RK] motif, discussed above, and are highlyFig. 7. Conserved, asymmetrical and transport-critical residues on the surface of the bovine
(a) residues critical for function in green, (b) conserved residues in orange, and (c) asymme
views are related to each other by 120° rotation to emphasise the three-fold pseudo-symmconserved and three-fold symmetric in members of the mitochondrial
carrier family. They could be involved in the proposed cytosolic gate, as
they are bulky aromatic residues that could close the carrier in the
matrix state.
4.4. Search for a dimerisation interface
The oxoglutarate carrier, like other mitochondrial carriers, was
believed to exist and function as a homo-dimer [29,30]. The inner
membrane of mammalian mitochondria contains around 50 different
mitochondrial carriers [10–14,31]. If speciﬁc homo-dimerswere to form
in the presence of many structurally related but functionally different
carriers, one would expect that dimerisation be mediated by speciﬁc
protein-protein interactions. The completion of the cys-scanning
mutagenesis of OGC permits analysis of putative dimerisation interfaces
since their residues are likely to be critical for transport, conserved
within the OGC subfamily, asymmetrically distributed (since three-fold
symmetrical residues are incompatible interfaces for a dimer) and
clustered together on the surface. There are only 26 functionally
important residues on the surface of OGC (Fig. 7a), but most belong to
thematrix gate, the recently proposed cytoplasmic gate, the EGmotif at
the C-terminal end of thematrixα-helices, and the [WYF][RK]Gmotif at
the N-terminus of the even-numbered α-helices. The remainingoxoglutarate carrier. Surface representation of the comparative model of OGC showing
tric residues in a colour scale from white (neutral) to red (highly asymmetric) [18]. The
etry.
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(Fig. 2) that do not have the ability to form strong and speciﬁc
interactions; R158, R159 (Fig. 2) (in the loop region between
transmembrane α-helix H3 and matrix α-helix h34) that are both
positively charged; andN163 (Fig. 2)which is not conserved. Thus, none
of the functionally relevant residues located on the surface of OGC are
likely to be involved in a speciﬁc homo-dimer interaction. Consistent
with this conclusion, the conservation analysis shows that most of the
57 strictly conserved amino acid residues on the surface of OGC (Fig. 7b)
are found in the above-mentioned motifs that are present in all
mitochondrial carriers and in all sequence repeats and thus cannot form
a speciﬁc interaction interface for homo-dimerisation of OGC. The
remaining conserved residues are glycines and prolines, such as G100,
P154, P186, G290 and P291 which form kinks [11] and inter-helical
interactions, and hydrophobic (V37, A92, A200, L180, F276, and F282)
and polar residues (T93, Q204, T283 and Q302) that are widespread on
the OGC surface and thus unlikely to form a speciﬁc interface. Finally, a
third criterion used to inspect the residues on the surface of OGC is the
deviation from three-fold pseudo-symmetry, which is required for
speciﬁc homo-dimerisation. The asymmetric residues of the loop
regions on the cytoplasmic and matrix side are not conserved in the
OGC subfamily, and thus unlikely to be involved in dimerisation.
Therefore, S19, K21, G100, P117, V164, I185, V193, S201, D217 and I298
are the only asymmetric residues thatmight be potential candidates for
speciﬁc recognition (Fig. 7c). Most strikingly, none of these asymmetric
residues, apart from G100, is conserved and critical for function. On the
basis of all these criteria, there is noevidence for thepresence of a homo-
dimerisation interface in OGC.
4.5. Concluding remarks
In conclusion, the systematic mutagenesis of the mitochondrial
oxoglutarate carrier has nowbeen completed, allowing for theﬁrst time
the identiﬁcation of all of the areas that are critical for its function. The
most critical residues can be found in the matrix salt-bridge network
and in its immediate environment. These residues are involved in the
formation of thematrix gate, but also in the interactionswith thematrix
α-helices, showing that they play a central role in the transport
mechanism. Another set of critical residues belong to the recently
hypothesized cytoplasmic salt-bridge network, which could form the
cytoplasmic gate when the substrate binding site is accessible from the
mitochondrialmatrix. Finally, in the central part of the cavity in between
the two networks are the residues of the substrate binding site, which
cannot be changed or modiﬁed either. The function and structural
arrangement of thematrix gate is consistentwith the crystal structure of
the ADP/ATP carrier, but the hypothesized cytosolic gate and substrate
binding site need to be conﬁrmed by structural data.
Supplementarymaterials related to this article can be found online
at doi:10.1016/j.bbabio.2010.12.005.
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